Epizyme Statistics
Share Statistics
Epizyme has 0
shares outstanding. The number of shares has increased by 61.68%
in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | 61.68% |
| Shares Change (QoQ) | 61.68% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -1.01 and the forward
PE ratio is null.
Epizyme's PEG ratio is
-0.12.
| PE Ratio | -1.01 |
| Forward PE | n/a |
| PS Ratio | 6.74 |
| Forward PS | n/a |
| PB Ratio | -12.2 |
| P/FCF Ratio | -1.11 |
| PEG Ratio | -0.12 |
Financial Ratio HistoryEnterprise Valuation
Epizyme has an Enterprise Value (EV) of 393.18M.
| EV / Sales | 10.51 |
| EV / EBITDA | -1.77 |
| EV / EBIT | -1.73 |
| EV / FCF | -1.73 |
Financial Position
The company has a current ratio of 4.56,
with a Debt / Equity ratio of -11.56.
| Current Ratio | 4.56 |
| Quick Ratio | 4.49 |
| Debt / Equity | -11.56 |
| Debt / EBITDA | -1.08 |
| Debt / FCF | -1.05 |
| Interest Coverage | -9.39 |
Financial Efficiency
Return on Equity is 1213.85% and Return on Invested Capital is -103.91%.
| Return on Equity | 1213.85% |
| Return on Assets | -86.89% |
| Return on Invested Capital | -103.91% |
| Revenue Per Employee | $149,708 |
| Profits Per Employee | $-1,004,488 |
| Employee Count | 250 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 3.26 |
Taxes
| Income Tax | 22K |
| Effective Tax Rate | -0.01% |
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is -0.42, so Epizyme's
price volatility has been lower than the market average.
| Beta | -0.42 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.21 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 61.3 |
| Average Volume (20 Days) | 4,181,034 |
Income Statement
In the last 12 months, Epizyme had revenue of 37.43M
and earned -251.12M
in profits. Earnings per share was -2.49.
| Revenue | 37.43M |
| Gross Profit | 26.93M |
| Operating Income | -226.94M |
| Net Income | -251.12M |
| EBITDA | -221.69M |
| EBIT | -215.88M |
| Earnings Per Share (EPS) | -2.49 |
Full Income StatementBalance Sheet
The company has 98.34M in cash and 239.11M in
debt, giving a net cash position of -140.78M.
| Cash & Cash Equivalents | 98.34M |
| Total Debt | 239.11M |
| Net Cash | -140.78M |
| Retained Earnings | -1.24B |
| Total Assets | n/a |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -226.85M
and capital expenditures -486K, giving a free cash flow of -227.34M.
| Operating Cash Flow | -226.85M |
| Capital Expenditures | -486K |
| Free Cash Flow | -227.34M |
| FCF Per Share | -2.25 |
Full Cash Flow StatementMargins
Gross margin is 71.95%, with operating and profit margins of -606.35% and -670.96%.
| Gross Margin | 71.95% |
| Operating Margin | -606.35% |
| Pretax Margin | -670.91% |
| Profit Margin | -670.96% |
| EBITDA Margin | -592.33% |
| EBIT Margin | -606.35% |
| FCF Margin | -607.42% |
